All the results above suggested that although BMAL1 did not alter the symptoms of CH once cardiomyocytes become hypertrophic, it was effective in reducing the apoptosis of hypertrophic cardiomyocytes. The gene discussed is BMAL1; the disease is cyclic hematopoiesis.